Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Anji Pharmaceuticals Inc.

www.anjipharma.com

Latest From Anji Pharmaceuticals Inc.

Deal Watch: Allergan, Celgene, AstraZeneca Among Biopharmas Advancing Existing Partnerships

Recent deal-making has seen new developments to further existing agreements, including Allergan licensing a depression candidate from the spinout of a company it bought in 2015. Also, updates on deals involving Celgene, AstraZeneca and Daiichi Sankyo.

Deals Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Anji Pharmaceuticals Inc.
  • Senior Management
  • Yiwei Zong, PhD, CEO
    Brian Hubbard , PhD, CSO
    Dan Meyers, MD, CMO
    Li (Lillian) Liang, Head, Reg. Affairs
    Michael Serrano-Wu, PhD, Head, Research
  • Contact Info
  • Anji Pharmaceuticals Inc.
    Shanghai,
    China
Advertisement
Advertisement
UsernamePublicRestriction

Register